ATE535523T1 - Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten - Google Patents
Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonistenInfo
- Publication number
- ATE535523T1 ATE535523T1 AT06760341T AT06760341T ATE535523T1 AT E535523 T1 ATE535523 T1 AT E535523T1 AT 06760341 T AT06760341 T AT 06760341T AT 06760341 T AT06760341 T AT 06760341T AT E535523 T1 ATE535523 T1 AT E535523T1
- Authority
- AT
- Austria
- Prior art keywords
- benzimidazolecarbonic
- acid amide
- receptor agonists
- amide compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68447805P | 2005-05-25 | 2005-05-25 | |
US68446605P | 2005-05-25 | 2005-05-25 | |
US74841505P | 2005-12-08 | 2005-12-08 | |
PCT/US2006/020085 WO2006127815A2 (en) | 2005-05-25 | 2006-05-24 | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE535523T1 true ATE535523T1 (de) | 2011-12-15 |
Family
ID=37452788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06760341T ATE535523T1 (de) | 2005-05-25 | 2006-05-24 | Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten |
Country Status (27)
Country | Link |
---|---|
US (10) | US7759363B2 (de) |
EP (1) | EP1899324B1 (de) |
JP (2) | JP5072111B2 (de) |
KR (1) | KR101333280B1 (de) |
AR (1) | AR057327A1 (de) |
AT (1) | ATE535523T1 (de) |
AU (1) | AU2006250009B2 (de) |
BR (1) | BRPI0611202C1 (de) |
CA (1) | CA2607280C (de) |
CY (1) | CY1112366T1 (de) |
DK (1) | DK1899324T3 (de) |
EA (1) | EA013240B1 (de) |
ES (1) | ES2376115T3 (de) |
HK (1) | HK1110980A1 (de) |
HR (1) | HRP20120108T2 (de) |
IL (1) | IL186883A (de) |
MA (1) | MA29541B1 (de) |
MX (1) | MX2007014762A (de) |
MY (1) | MY147756A (de) |
NO (1) | NO339658B1 (de) |
NZ (1) | NZ563068A (de) |
PE (1) | PE20061446A1 (de) |
PL (1) | PL1899324T3 (de) |
PT (1) | PT1899324E (de) |
SI (1) | SI1899324T1 (de) |
TW (1) | TWI388555B (de) |
WO (1) | WO2006127815A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2377484T3 (es) * | 2003-09-03 | 2012-03-28 | Pfizer, Inc. | Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-HT |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
MY147756A (en) * | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
US7256294B2 (en) * | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
AU2010229142A1 (en) * | 2009-03-23 | 2011-10-13 | Merck Sharp & Dohme Corp. | P2X3, receptor antagonists for treatment of pain |
AU2010236734B2 (en) * | 2009-04-13 | 2015-06-11 | Theravance Biopharma R&D Ip, Llc | 5-HT4 receptor agonist compounds for treatment of cognitive disorders |
JP2013518085A (ja) | 2010-02-01 | 2013-05-20 | ノバルティス アーゲー | CRF−1受容体アンタゴニストとしてのピラゾロ[5,1b]オキサゾール誘導体 |
WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
ES2527849T3 (es) | 2010-02-02 | 2015-01-30 | Novartis Ag | Derivados de ciclohexilamida como antagonistas del receptor de CRF |
JP2015057381A (ja) | 2013-08-09 | 2015-03-26 | 参天製薬株式会社 | 3,3−ジメチル−3,4−ジヒドロ−1h−キノキサリン−2−オン誘導体の製造方法およびその製造方法の中間体 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO984B1 (en) * | 1977-10-11 | 1979-12-01 | بيتشام غروب ليمتد | A dry pharmaceutical compound with a suitable dosage unit for oral administration |
ES2109190B1 (es) | 1996-03-22 | 1998-07-01 | Univ Madrid Complutense | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
KR20010043032A (ko) * | 1998-04-28 | 2001-05-25 | 도모따께 다께시 | 1-[(1-치환-4-피페리디닐)메틸]-4-피페리딘 유도체, 그의제조방법, 그것을 함유하는의약조성물 및 이 화합물의중간체 |
JP2002528531A (ja) | 1998-11-03 | 2002-09-03 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換2−フェニルベンズイミダゾール、その製造法および使用 |
US6353005B1 (en) * | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
ES2154605B1 (es) | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
JP2001122784A (ja) | 1999-10-27 | 2001-05-08 | Dainippon Pharmaceut Co Ltd | 1−[(1−置換−4−ピペリジニル)メチル]−4−ピペリジン誘導体からなる医薬 |
AU2001275326C1 (en) * | 2000-06-07 | 2006-09-21 | Aryx Therapeutics | Treatment of gastroesophageal reflux disease using piperidine derivatives |
US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
DE60313634T2 (de) | 2002-08-05 | 2008-01-31 | Eli Lilly And Co., Indianapolis | Piperazinsubstituierte arylbenzodiazepine |
BR0314584A (pt) * | 2002-09-20 | 2005-08-09 | Pfizer | Compostos piperidinil-imidazopiridina n-substituìda como moduladores e receptores 5-ht4 |
JP2004277320A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | 1,4−ジ置換ピペリジン誘導体およびそれを含有する医薬組成物 |
JP2004277319A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | 1−(4−ピペリジニルメチル)ピペリジニルアミド誘導体およびそれを含有する医薬組成物 |
JP2004277318A (ja) * | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | 1−(1−置換カルボニル−4−ピペリジニルメチル)ピペリジン誘導体およびそれを含有する医薬組成物 |
ES2377484T3 (es) * | 2003-09-03 | 2012-03-28 | Pfizer, Inc. | Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-HT |
MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
US7256294B2 (en) | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
-
2006
- 2006-05-17 MY MYPI20062263A patent/MY147756A/en unknown
- 2006-05-22 TW TW095118168A patent/TWI388555B/zh active
- 2006-05-23 PE PE2006000543A patent/PE20061446A1/es active IP Right Grant
- 2006-05-24 EA EA200702612A patent/EA013240B1/ru not_active IP Right Cessation
- 2006-05-24 PL PL06760341T patent/PL1899324T3/pl unknown
- 2006-05-24 AT AT06760341T patent/ATE535523T1/de active
- 2006-05-24 EP EP06760341A patent/EP1899324B1/de active Active
- 2006-05-24 US US11/439,671 patent/US7759363B2/en active Active
- 2006-05-24 AU AU2006250009A patent/AU2006250009B2/en not_active Ceased
- 2006-05-24 PT PT06760341T patent/PT1899324E/pt unknown
- 2006-05-24 JP JP2008513672A patent/JP5072111B2/ja not_active Expired - Fee Related
- 2006-05-24 AR ARP060102166A patent/AR057327A1/es active IP Right Grant
- 2006-05-24 CA CA2607280A patent/CA2607280C/en active Active
- 2006-05-24 BR BRPI0611202A patent/BRPI0611202C1/pt not_active IP Right Cessation
- 2006-05-24 WO PCT/US2006/020085 patent/WO2006127815A2/en active Application Filing
- 2006-05-24 US US11/920,817 patent/US8143279B2/en not_active Expired - Fee Related
- 2006-05-24 ES ES06760341T patent/ES2376115T3/es active Active
- 2006-05-24 KR KR1020077030010A patent/KR101333280B1/ko active IP Right Grant
- 2006-05-24 MX MX2007014762A patent/MX2007014762A/es active IP Right Grant
- 2006-05-24 NZ NZ563068A patent/NZ563068A/en not_active IP Right Cessation
- 2006-05-24 DK DK06760341.5T patent/DK1899324T3/da active
- 2006-05-24 SI SI200631257T patent/SI1899324T1/sl unknown
-
2007
- 2007-10-24 IL IL186883A patent/IL186883A/en active IP Right Grant
- 2007-12-10 MA MA30466A patent/MA29541B1/fr unknown
- 2007-12-17 NO NO20076481A patent/NO339658B1/no not_active IP Right Cessation
-
2008
- 2008-05-19 HK HK08105518.4A patent/HK1110980A1/xx not_active IP Right Cessation
-
2010
- 2010-06-09 US US12/796,902 patent/US8377964B2/en active Active
-
2012
- 2012-02-01 HR HR20120108T patent/HRP20120108T2/hr unknown
- 2012-02-17 CY CY20121100168T patent/CY1112366T1/el unknown
- 2012-07-23 JP JP2012162692A patent/JP2012197322A/ja not_active Withdrawn
-
2013
- 2013-01-16 US US13/742,783 patent/US20130273568A1/en not_active Abandoned
-
2014
- 2014-09-17 US US14/488,520 patent/US9428489B2/en active Active
-
2016
- 2016-07-28 US US15/221,841 patent/US9975877B2/en active Active
-
2018
- 2018-04-19 US US15/956,958 patent/US10233172B2/en active Active
-
2019
- 2019-01-29 US US16/260,984 patent/US10696656B2/en active Active
-
2020
- 2020-05-22 US US16/881,209 patent/US11254655B2/en active Active
-
2022
- 2022-01-12 US US17/573,814 patent/US20220274957A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE420088T1 (de) | Chinolinoncarbonsäureamidverbindungen als 5-ht4- rezeptoragonisten | |
LTC2004635I2 (lt) | Pakeistieji enaminokarbonilo junginiai | |
ATE535523T1 (de) | Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten | |
ATE513827T1 (de) | Oxyindol-derivate als 5ht4-rezeptor-agonisten | |
ATE549350T1 (de) | Neuropeptid-2-rezeptor-agonisten | |
ATE504559T1 (de) | Arylanilinderivate als agonisten des beta2- adrenergen rezeptors | |
ATE435207T1 (de) | Pyridin-3-carbonsäureamidderivate als cb1-inverse agonisten | |
DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
DE602006003628D1 (de) | Purinderivate als a2a-rezeptoragonisten | |
CY2013047I1 (el) | Ενωσεις διαρυλυδαντοϊνης | |
ATE509927T1 (de) | Indolderivate als s1p1-rezeptor-agonisten | |
DE602006019624D1 (de) | Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors | |
DK1919907T5 (da) | Heterocyklisk forbindelse | |
DK1937650T3 (da) | Heterocykliske forbindelser | |
ATE443056T1 (de) | Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen | |
ATE429428T1 (de) | Indanderivate als antagonisten des mch-rezeptors | |
ATE421511T1 (de) | Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors | |
DK1973886T3 (da) | Prokineticin-1-receptor-antagonister | |
ATE509925T1 (de) | Substituierte bicyclocarbonsäureamidverbindungen | |
ATE435225T1 (de) | Oxadiazolonderivate als ppar-delta-agonisten | |
DK1931309T3 (da) | Antimykotisk sammensætning | |
ATE459618T1 (de) | 3-piperidinylisochroman-5-ole als dopaminagonisten | |
ZA200707142B (en) | Quinolinone compounds as 5-HT4 receptor agonists | |
DE602006015186D1 (de) | Oxindole als kinaseinhibitoren | |
DE602006008002D1 (de) | Benzofuranylderivate als 5-ht6-rezeptorinhibitoren |